Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05905146

Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain.

Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain. Multicenter, Randomized, Controlled Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate whether patients who benefit from a personalized pharmaceutical plan (PPP) during their hospitalization, allowing them to be informed and sensitized, are treated for a shorter period of time with strong opioids with a reduced risk of dependence compared to a management according to the usual modalities in the rheumatology services concerned.

Conditions

Interventions

TypeNameDescription
OTHERpersonalized pharmaceutical planmulti-professional intervention around strong opioid treatment with targeted pharmaceutical interview

Timeline

Start date
2024-01-18
Primary completion
2028-07-18
Completion
2028-07-18
First posted
2023-06-15
Last updated
2026-02-06

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05905146. Inclusion in this directory is not an endorsement.

Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeleta (NCT05905146) · Clinical Trials Directory